Vertebral Fractures Up With Long-Term Delay of Denosumab

TUESDAY, July 28, 2020 -- Compared with on-time dosing, delay of denosumab by more than 16 weeks is associated with an increased risk for vertebral fractures, according to a study published online July 28 in the Annals of Internal Medicine. Houchen...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news